These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31379947)

  • 1. Corrigendum to "Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update".
    Villafuerte-Gutierrez P; Villalon L; Losa JE; Henriquez-Camacho C
    Adv Hematol; 2019; 2019():4120631. PubMed ID: 31379947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.
    Villafuerte-Gutierrez P; Villalon L; Losa JE; Henriquez-Camacho C
    Adv Hematol; 2014; 2014():986938. PubMed ID: 25525436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
    Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
    Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A; Bucaneve G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
    Whited L; Grove M; Rose D; Rhodes NJ; Scheetz MH; O'Donnell JN; Neeb J; Thoele K; Jones DR; Lowe C; Moore D; Kiel PJ
    Pharmacotherapy; 2016 Sep; 36(9):1003-10. PubMed ID: 27496678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study.
    Ludwig H; Bokemeyer C; Aapro M; Boccadoro M; Gascón P; Denhaerynck K; Krendyukov A; Abraham I; MacDonald K
    Future Oncol; 2019 Mar; 15(8):897-907. PubMed ID: 30827127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the management of febrile neutropenia in hematologic patients.
    Escrihuela-Vidal F; Laporte J; Albasanz-Puig A; Gudiol C
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 2(Suppl 2):55-58. PubMed ID: 31475812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
    Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
    Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Footwear exchange has no influence on the incidence of febrile neutropenia in patients undergoing chemotherapy for hematologic malignancies.
    Sugahara H; Mizuki M; Matsumae S; Nabetani Y; Kikuchi M; Kanakura Y
    Infect Control Hosp Epidemiol; 2004 Jan; 25(1):51-4. PubMed ID: 14756220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
    Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
    Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and microbiological effects of biapenem in febrile neutropenic patients with hematologic malignancies.
    Isobe Y; Kanemitsu N; Yahata Y; Masuda A; Tsukune Y; Sugimoto K
    Scand J Infect Dis; 2009; 41(3):237-9. PubMed ID: 19116887
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies.
    Timmers GJ; van Vuurden DG; Swart EL; Simoons-Smit AM; Huijgens PC
    Haematologica; 2005 Jul; 90(7):1005-6. PubMed ID: 15996951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies.
    Nenova IS; Goranov SE; Mateva NG; Ananoshtev NH
    Folia Med (Plovdiv); 2003; 45(1):13-9. PubMed ID: 12943062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fever profile of febrile neutropenia in patients treated with cancer chemotherapy for hematological malignancies].
    Tamai Y; Imataki O; Kawakami K
    Gan To Kagaku Ryoho; 2010 May; 37(5):859-62. PubMed ID: 20495316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention of febrile neutropenia.
    Pascoe J; Cullen M
    Curr Opin Oncol; 2006 Jul; 18(4):325-9. PubMed ID: 16721125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia.
    Butts AR; Bachmeier CC; Dressler EV; Liu M; Cowden A; Talbert J; Adams VR
    J Oncol Pharm Pract; 2017 Jun; 23(4):278-283. PubMed ID: 28077045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of imipenem 1.5 g daily in febrile patients with short duration neutropenia after chemotherapy for non-leukemic hematologic malignancies and solid tumors: personal experience and review of the literature.
    Jourdan E; Defez C; Topart D; Richard B; Bellabas H; Fabbro-Peray P; Jourdan J; Sotto A
    Leuk Lymphoma; 2003 Apr; 44(4):619-26. PubMed ID: 12769338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.